(NYSE:PRMB), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired (i) the common stock of Primo Water Corporation (“Primo Water”) between June 17, 2024 through November 8, 2024, inclusive, and/or (ii) the […]

(NasdaqGM:FLY), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired: (a) Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ: FLY) common stock pursuant and/or traceable to the Offering Documents issued in connection

(NASDAQ:SLM), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of SLM Corporation a/k/a Sallie Mae (“SLM” or the “Company”) (NASDAQ: SLM) between July 25, 2025 and August 14, 2025,

(NASDAQ:FFIV), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of F5, Inc. (“F5” or the “Company”) (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, inclusive. Should You

(NYSE:LRN), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) between October 22, 2024 and October 28, 2025, inclusive. Should You

(NASDAQ:GNLX), — Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ongoing – — In platinum-relapsed or platinum-refractory advanced SCLC, two of three partial responses (PRs) occurred in the highest dose cohort tested as of the data review cutoff date

(NASDAQ:MGNI), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will host in-person investor meetings at the Needham 28th Annual Growth Conference in New York City on Wednesday, January 14. Company management will participate in a fireside chat at

(NYSE:GFF), Las Vegas, NV, Jan. 05, 2026 (GLOBE NEWSWIRE) — Hunter Fan Company, the leading ceiling fan manufacturer, will debut its newest smart home product innovations at Pepcom's Digital Experience!┇, an exclusive media showcase, on January 5, 2026, in Las Vegas. Developed as the definitive solution for connected whole-home comfort, the newest HunterSMART(TM) collection is

(NASDAQ:CRNX), Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Atumelnant (80 mg) Achieved a 67% Mean Reduction in Androstenedione Levels While Simultaneously Enabling 88% of Participants Completing 12 Weeks of Treatment to Successfully Reduce Glucocorticoid

(PinkSheets:BCDS),(Pinksheets:BCDS), ROBESONIA, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) — BLAQclouds, Inc. (OTC: BCDS) today announced the full-scale merchant launch of BLAQpay.io, the graduated commercial platform emerging from DiVinciPay V1 and ZEUSxPay V2 & V3. BLAQpay represents a major milestone in the Company's 2026 roadmap and is the second platform following the successful launch of ApolloCASH.io,